BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37902470)

  • 1. Impact of delay of local control in nonmetastatic extremity primary osteosarcoma.
    Halalsheh H; Ismael T; Boheisi M; Shehadeh A; Sultan I
    Pediatr Blood Cancer; 2024 Jan; 71(1):e30752. PubMed ID: 37902470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of bony resection margins and surgicopathological factors on outcomes in limb-sparing surgery for extremity osteosarcoma.
    Loh AH; Wu H; Bahrami A; Navid F; McCarville MB; Wang C; Wu J; Bishop MW; Daw NC; Neel MD; Rao BN
    Pediatr Blood Cancer; 2015 Feb; 62(2):246-251. PubMed ID: 25381958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do Surgical Margins Affect Local Recurrence and Survival in Extremity, Nonmetastatic, High-grade Osteosarcoma?
    Bertrand TE; Cruz A; Binitie O; Cheong D; Letson GD
    Clin Orthop Relat Res; 2016 Mar; 474(3):677-83. PubMed ID: 26013153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How Are Indeterminate Pulmonary Nodules at Diagnosis Associated with Survival in Patients with High-Grade Osteosarcoma?
    Tsoi KM; Lowe M; Tsuda Y; Lex JR; Fujiwara T; Almeer G; Gregory J; Stevenson J; Evans SE; Botchu R; Jeys LM
    Clin Orthop Relat Res; 2021 Feb; 479(2):298-308. PubMed ID: 32956141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience of pediatric osteosarcoma of the extremity at a single institution in Taiwan: prognostic factors and impact on survival.
    Hung GY; Yen HJ; Yen CC; Chen WM; Chen PC; Wu HT; Chiou HJ; Chang WH; Hsu HE
    Ann Surg Oncol; 2015 Apr; 22(4):1080-7. PubMed ID: 25323470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What are the factors that affect survival and relapse after local recurrence of osteosarcoma?
    Takeuchi A; Lewis VO; Satcher RL; Moon BS; Lin PP
    Clin Orthop Relat Res; 2014 Oct; 472(10):3188-95. PubMed ID: 24980644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age and Tumor Location Predict Survival in Nonmetastatic Osteosarcoma in Upper Egypt.
    Morsy AM; Ahmed BM; Rezk KM; Ramadan IK; Aboelgheit AM; Eltyb HA; Abd Elbadee OM; El-Naggar MS
    J Pediatr Hematol Oncol; 2020 Mar; 42(2):e66-e78. PubMed ID: 31107367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group.
    Provisor AJ; Ettinger LJ; Nachman JB; Krailo MD; Makley JT; Yunis EJ; Huvos AG; Betcher DL; Baum ES; Kisker CT; Miser JS
    J Clin Oncol; 1997 Jan; 15(1):76-84. PubMed ID: 8996127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase 2 study for nonmetastatic extremity high-grade osteosarcoma in pediatric and adolescent and young adult patients with a risk-adapted strategy based on ABCB1/P-glycoprotein expression: An Italian Sarcoma Group trial (ISG/OS-2).
    Palmerini E; Meazza C; Tamburini A; Bisogno G; Ferraresi V; Asaftei SD; Milano GM; Coccoli L; Manzitti C; Luksch R; Serra M; Gambarotti M; Donati DM; Scotlandi K; Bertulli R; Favre C; Longhi A; Abate ME; Perrotta S; Mascarin M; D'Angelo P; Cesari M; Staals EL; Marchesi E; Carretta E; Ibrahim T; Casali PG; Picci P; Fagioli F; Ferrari S
    Cancer; 2022 May; 128(10):1958-1966. PubMed ID: 35201621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant Chemotherapy Followed by Delayed Surgery: Is it Necessary for All Patients With Nonmetastatic High-Grade Pelvic Osteosarcoma?
    Xu J; Xie L; Guo W
    Clin Orthop Relat Res; 2018 Nov; 476(11):2177-2186. PubMed ID: 29912746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution.
    Bacci G; Longhi A; Versari M; Mercuri M; Briccoli A; Picci P
    Cancer; 2006 Mar; 106(5):1154-61. PubMed ID: 16421923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is Microscopic Vascular Invasion in Tumor Specimens Associated with Worse Prognosis in Patients with High-grade Localized Osteosarcoma?
    Tsuda Y; Tsoi K; Stevenson JD; Parry MC; Fujiwara T; Sumathi V; Jeys LM
    Clin Orthop Relat Res; 2020 Jun; 478(6):1190-1198. PubMed ID: 31904683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression before local control in osteosarcoma: Outcome and prognosis-predictive factors.
    Halalsheh H; Amer S; Sultan I
    Pediatr Blood Cancer; 2023 Nov; 70(11):e30649. PubMed ID: 37638816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Childhood osteosarcoma: multimodal therapy in a single-institution Turkish series.
    Ayan I; Kebudi R; Ozger H
    Cancer Treat Res; 2009; 152():319-38. PubMed ID: 20213399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the Prognostic Significance of Histologic Response in Osteosarcoma: A Comparison of Outcomes on CCG-782 and INT0133-A Report From the Children's Oncology Group Bone Tumor Committee.
    Bishop MW; Chang YC; Krailo MD; Meyers PA; Provisor AJ; Schwartz CL; Marina NM; Teot LA; Gebhardt MC; Gorlick R; Janeway KA; Chou AJ
    Pediatr Blood Cancer; 2016 Oct; 63(10):1737-43. PubMed ID: 27128693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of bone and soft-tissue sarcomas registered during the year 2012 at Tata Memorial Hospital, Mumbai, with clinical outcomes.
    Bajpai J; Khanna N; Vora T; Gulia A; Laskar S; Puri A; Sanduptla B; Chinnaswamy G; Nayak P; Juvekar SL; Janu A; Desai S; Ghosh J; Purandare N; Ramadwar M; Rangarajan V; Rekhi B
    Indian J Cancer; 2018; 55(1):37-44. PubMed ID: 30147091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathological Fracture and Prognosis of High-Grade Osteosarcoma of the Extremities: An Analysis of 2,847 Consecutive Cooperative Osteosarcoma Study Group (COSS) Patients.
    Kelley LM; Schlegel M; Hecker-Nolting S; Kevric M; Haller B; Rössig C; Reichardt P; Kager L; Kühne T; Gosheger G; Windhager R; Specht K; Rechl H; Tunn PU; Baumhoer D; Wirth T; Werner M; von Kalle T; Nathrath M; Burdach S; Bielack S; von Lüttichau I
    J Clin Oncol; 2020 Mar; 38(8):823-833. PubMed ID: 31928458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The extremity localized classic osteosarcomas have better survival than the axial non-classics.
    Lin L; Deng S; Zhang F; Liang Y; Huang Z
    World J Surg Oncol; 2018 Feb; 16(1):39. PubMed ID: 29471883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What has changed in the last 25 years in osteosarcoma treatment? A single center experience.
    Ataseven E; Göktepe ŞÖ; Kaya H; Tamsel İ; Keçeci B; Argın M; Doğanavşargil B; Sabah D; Burak Z; Kantar M
    Turk J Pediatr; 2023; 65(1):54-63. PubMed ID: 36866985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric Osteosarcoma of Extremities: A 15-year Experience From a Tertiary Care Cancer Center in Upper Egypt.
    Morsy AM; Abdelgawad MI; Ahmed BM; Rezk KM; Aboelgheit AM; Ramadan IK; Kamel HEM; Fouad DM; Herdan RA; Shabaan SH; Eltyb HA
    J Pediatr Hematol Oncol; 2019 Aug; 41(6):e371-e383. PubMed ID: 30629005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.